INVENTA THERAPEUTICS LIMITED
Company number 11032260 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£125
Balance sheet as at 2019-10-31
What it does
The principal activity of the company is specialising in drug development.
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2017-10-25
- Employees
- 4 (2024 accounts)
- Registered office
- 10 Colwick Quays Business Park Road No 2, Colwick, Nottingham, England, NG4 2JY
- Postcode
- NG4 2JY
- Capital
- 125 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2024-12-31
- Next due by
- 2026-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2025-10-25
- Next due by
- 2026-11-08
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 4 current
Contact details
- Website
- inventatherapeutics.com
Bio-Pharmaceutical Organization, inventing and delivering improved therapies within Immunology and Inflammation Therapeutic areas
Previous registered addresses 1
| Address | Changed on |
|---|---|
| 26 SWAINS AVENUE, BAKERSFIELD, NOTTINGHAM, NG3 7AS, UNITED KINGDOM | 2019-01-22 |
Competitors Nottingham
This company ranks 34 among research and experimental development on biotechnology in Nottingham.
The class of 2017
37%
of the 435 companies in this sector incorporated in 2017 are still active today; 61% have since been dissolved.
A fact about the year, not a forecast for this company.